Lab freeze dryers and lyopholizers & accessories

LF648 WINTER LINER

Biochem/physiol Actions LY320135 is a potent CB1 receptor antagonist/inverse agonist (Ki = 141 nM) with greater than 70-fold selectivity over CB2 receptors (Ki &gt: 10 &#956:M). Structurally dissimilar from SR 141716A and AM 251.

Biochem/physiol Actions LY2955303 is a potent and selective RAR&#947: antagonist (Ki = 1.09 nM/RAR&#947:, &gt:1.

Biochem/physiol Actions LY2955303 is a potent and selective RAR&#947: antagonist (Ki = 1.09 nM/RAR&#947:, &gt:1.

Biochem/physiol Actions LY2603618 (LCI-1) is a potent and selective checkpoint kinase 1 (Chk1) inhibitor (IC 50 = 7 nM) that produces a cellular phenotype identical to that reported upon Chk1 depletion by RNAi. LY2603618 prevents

Biochem/physiol Actions LY2603618 (LCI-1) is a potent and selective checkpoint kinase 1 (Chk1) inhibitor (IC 50 = 7 nM) that produces a cellular phenotype identical to that reported upon Chk1 depletion by RNAi. LY2603618 prevents

Biochem/physiol Actions LY2828360 is a potent and selective slowly acting G protein-biased CB2 cannabinoid agonist that inhibits cAMP accumulation and activates ERK1/2 signaling while failing to recruit arrestin. LY2828360 suppress

Biochem/physiol Actions LY2828360 is a potent and selective slowly acting G protein-biased CB2 cannabinoid agonist that inhibits cAMP accumulation and activates ERK1/2 signaling while failing to recruit arrestin. LY2828360 suppress

Biochem/physiol Actions LY345899 (LY354899) is a methylenetetrahydrofolate dehydrogenase inhibitor (MTHFD1 IC50 = 96 nM with 30 &#956:M folitixorin and 400 &#956:M NADP+: MTHFD2 IC50 = 663 nM with 5 &#956:M folitixorin and 250 &#956:M NAD+) that

Biochem/physiol Actions LY345899 (LY354899) is a methylenetetrahydrofolate dehydrogenase inhibitor (MTHFD1 IC50 = 96 nM with 30 &#956:M folitixorin and 400 &#956:M NADP+: MTHFD2 IC50 = 663 nM with 5 &#956:M folitixorin and 250 &#956:M NAD+) that

250mL LeThena SU Freezing Bags - 3ports

250mL LeThena SU Freezing Bags - 2 ports